Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market

Go back to Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
(NASDAQ: INBS) Delayed: 1.81 +0.01 (0.56%)
Previous Close $1.80    52 Week High
Open $1.80    52 Week Low
Day High $1.88    P/E N/A 
Day Low $1.75    EPS
Volume 58,561       

(NASDAQ: INBS) Delayed: 1.81 +0.01 (0.56%)
Previous Close $1.80    52 Week High
Open $1.80    52 Week Low
Day High $1.88    P/E N/A 
Day Low $1.75    EPS
Volume 58,561